Vector has reported its first-half result. Auckland community-owned energy distributor Vector said its capital expenditure would pick up in the second half after reporting a slight fall in first-half ...
Welcome to Edition 8.31 of the Rocket Report! We have some late-breaking news this week with an update Thursday afternoon ...
NASHVILLE, Tenn. (WSMV) - Clarice Phelps describes nuclear chemistry a little differently than most people would. “I got it relatively quickly, and it was easy, and I liked it, and it just kind of ...
AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been dosed in its ...
VTx-002 is a first-in-class vectorized antibody to holistically target TDP-43 pathology in ALS recently granted FDA Fast Track Designation for expedited review Amsterdam, The Netherlands, and Boston, ...
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VTx-002 is a first-in-class vectorized ...
The story of the last element to be discovered out of the first 92 catalogued in the periodic table is told by Eric Scerri, who reminds us that technetium can be found a little closer to home than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results